Filed: 5/12/2023ACC: 0000904454-23-000311
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $261.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$261.80M
Total AUM (reported)
21.01M
Total Shares
Allocation by class
COM$192.98M73.7%
SPON ADR$17.18M6.6%
COM NEW$16.88M6.4%
SPONSORED ADR$16.73M6.4%
SHS$16.07M6.1%
*W EXP 02/02/202$444.1K0.2%
*W EXP 09/30/202$353.2K0.1%
Portfolio Concentration
Top 3$56.00M21.4%
4–10$116.66M44.6%
11–25$88.51M33.8%
Rest$629.8K0.2%
Top 3 weight
21.4%
Top 10 weight
66.0%
Voting Authority Distribution
Total shares with voting rights: 21.01M
Sole
Full voting authority
21.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
TRAVERE THERAPEUTICS INC
SOLEShares875.22K
TypeSH
Market value$19.68M
7.52%
Sole
875.22K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares283.69K
TypeSH
Market value$18.71M
7.15%
Sole
283.69K
Shared
0.00
None
0.00
IVERIC BIO INC
SOLEShares723.60K
TypeSH
Market value$17.61M
6.72%
Sole
723.60K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares916.35K
TypeSH
Market value$17.25M
6.59%
Sole
916.35K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares444.66K
TypeSH
Market value$17.18M
6.56%
Sole
444.66K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares122.76K
TypeSH
Market value$16.92M
6.46%
Sole
122.76K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares156.07K
TypeSH
Market value$16.73M
6.39%
Sole
156.07K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares388.87K
TypeSH
Market value$16.32M
6.23%
Sole
388.87K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.46M
TypeSH
Market value$16.19M
6.19%
Sole
1.46M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares331.60K
TypeSH
Market value$16.07M
6.14%
Sole
331.60K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares614.23K
TypeSH
Market value$15.81M
6.04%
Sole
614.23K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares413.79K
TypeSH
Market value$14.56M
5.56%
Sole
413.79K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares868.43K
TypeSH
Market value$13.95M
5.33%
Sole
868.43K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares846.27K
TypeSH
Market value$13.94M
5.32%
Sole
846.27K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares492.30K
TypeSH
Market value$13.45M
5.14%
Sole
492.30K
Shared
0.00
None
0.00
CEREVEL THERAPEUTICS HLDNG I
SOLEShares539.45K
TypeSH
Market value$13.16M
5.03%
Sole
539.45K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares488.86K
TypeSH
Market value$2.32M
0.89%
Sole
488.86K
Shared
0.00
None
0.00
ARES ACQUISITION CORP
SOLEShares504.71K
TypeSH
Market value$444.1K
0.17%
Sole
504.71K
Shared
0.00
None
0.00
HOME PLATE ACQUISITION CORP
SOLEShares690K
TypeSH
Market value$218.7K
0.08%
Sole
690K
Shared
0.00
None
0.00
BRIDGETOWN HOLDINGS LTD
SOLEShares895K
TypeSH
Market value$134.4K
0.05%
Sole
895K
Shared
0.00
None
0.00
ROSS ACQUISITION CORP II
SOLEShares439.67K
TypeSH
Market value$115.2K
0.04%
Sole
439.67K
Shared
0.00
None
0.00
CONYERS PARK III ACQUISITION CORP
SOLEShares571.67K
TypeSH
Market value$114.3K
0.04%
Sole
571.67K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP V
SOLEShares612K
TypeSH
Market value$114.3K
0.04%
Sole
612K
Shared
0.00
None
0.00
MARBLEGATE ACQUISITION CORP
SOLEShares735K
TypeSH
Market value$110.2K
0.04%
Sole
735K
Shared
0.00
None
0.00
YS BIOPHARMA CO LTD
SOLEShares490K
TypeSH
Market value$76.3K
0.03%
Sole
490K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TRAVERE THERAPEUTICS INCSOLE | COM | 875.22K | SH | $19.68M 7.52% | 875.22K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 283.69K | SH | $18.71M 7.15% | 283.69K | 0.00 | 0.00 |
IVERIC BIO INCSOLE | COM | 723.60K | SH | $17.61M 6.72% | 723.60K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 916.35K | SH | $17.25M 6.59% | 916.35K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 444.66K | SH | $17.18M 6.56% | 444.66K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 122.76K | SH | $16.92M 6.46% | 122.76K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 156.07K | SH | $16.73M 6.39% | 156.07K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | COM | 388.87K | SH | $16.32M 6.23% | 388.87K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.46M | SH | $16.19M 6.19% | 1.46M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 331.60K | SH | $16.07M 6.14% | 331.60K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 614.23K | SH | $15.81M 6.04% | 614.23K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 413.79K | SH | $14.56M 5.56% | 413.79K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 868.43K | SH | $13.95M 5.33% | 868.43K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 846.27K | SH | $13.94M 5.32% | 846.27K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 492.30K | SH | $13.45M 5.14% | 492.30K | 0.00 | 0.00 |
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 539.45K | SH | $13.16M 5.03% | 539.45K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 488.86K | SH | $2.32M 0.89% | 488.86K | 0.00 | 0.00 |
ARES ACQUISITION CORPSOLE | *W EXP 02/02/202 | 504.71K | SH | $444.1K 0.17% | 504.71K | 0.00 | 0.00 |
HOME PLATE ACQUISITION CORPSOLE | *W EXP 09/30/202 | 690K | SH | $218.7K 0.08% | 690K | 0.00 | 0.00 |
BRIDGETOWN HOLDINGS LTDSOLE | *W EXP 09/30/202 | 895K | SH | $134.4K 0.05% | 895K | 0.00 | 0.00 |
ROSS ACQUISITION CORP IISOLE | *W EXP 02/01/202 | 439.67K | SH | $115.2K 0.04% | 439.67K | 0.00 | 0.00 |
CONYERS PARK III ACQUISITION CORPSOLE | *W EXP 08/12/202 | 571.67K | SH | $114.3K 0.04% | 571.67K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VSOLE | *W EXP 10/29/202 | 612K | SH | $114.3K 0.04% | 612K | 0.00 | 0.00 |
MARBLEGATE ACQUISITION CORPSOLE | *W EXP 08/31/202 | 735K | SH | $110.2K 0.04% | 735K | 0.00 | 0.00 |
YS BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 490K | SH | $76.3K 0.03% | 490K | 0.00 | 0.00 |
Page 1 of 2